IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,659 | -49.3% | 734,640 | -39.7% | 0.02% | -39.4% |
Q2 2023 | $22,984 | +7460.5% | 1,218,040 | +1439.1% | 0.03% | – |
Q1 2023 | $304 | -100.0% | 79,140 | -95.4% | 0.00% | -100.0% |
Q3 2022 | $8,151,000 | +25.0% | 1,705,140 | +17.7% | 0.01% | +50.0% |
Q2 2022 | $6,519,000 | -6.3% | 1,448,740 | -0.9% | 0.01% | 0.0% |
Q1 2022 | $6,961,000 | -22.9% | 1,462,340 | +20.1% | 0.01% | -27.3% |
Q4 2021 | $9,033,000 | +39.5% | 1,217,387 | +6.6% | 0.01% | +37.5% |
Q3 2021 | $6,474,000 | -52.9% | 1,141,840 | -45.2% | 0.01% | -52.9% |
Q2 2021 | $13,734,000 | -9.0% | 2,084,090 | +11.8% | 0.02% | -10.5% |
Q1 2021 | $15,093,000 | -44.8% | 1,863,340 | -56.0% | 0.02% | -36.7% |
Q4 2020 | $27,322,000 | +17.0% | 4,235,966 | -34.7% | 0.03% | +30.4% |
Q3 2020 | $23,361,000 | -47.5% | 6,489,139 | -32.9% | 0.02% | -39.5% |
Q2 2020 | $44,460,000 | +18.4% | 9,665,139 | -12.3% | 0.04% | +5.6% |
Q1 2020 | $37,565,000 | -31.3% | 11,016,129 | +2.9% | 0.04% | -14.3% |
Q4 2019 | $54,660,000 | +165.0% | 10,707,139 | +25.6% | 0.04% | +147.1% |
Q3 2019 | $20,626,000 | +37.3% | 8,523,039 | +23.1% | 0.02% | +30.8% |
Q2 2019 | $15,022,000 | -21.3% | 6,922,640 | -1.7% | 0.01% | -23.5% |
Q1 2019 | $19,088,000 | -35.7% | 7,043,640 | +13.9% | 0.02% | -46.9% |
Q4 2018 | $29,674,000 | -50.4% | 6,182,140 | -2.1% | 0.03% | -47.5% |
Q3 2018 | $59,781,000 | -47.6% | 6,312,640 | -44.3% | 0.06% | -1.6% |
Q2 2018 | $114,049,000 | +125.6% | 11,331,240 | +135.8% | 0.06% | +12.7% |
Q1 2018 | $50,558,000 | +621.4% | 4,805,940 | +339.6% | 0.06% | +587.5% |
Q4 2017 | $7,008,000 | +74.7% | 1,093,240 | +108.5% | 0.01% | +60.0% |
Q3 2017 | $4,011,000 | -21.9% | 524,340 | -27.4% | 0.01% | -28.6% |
Q2 2017 | $5,136,000 | -10.2% | 722,340 | -51.1% | 0.01% | -12.5% |
Q1 2017 | $5,720,000 | +13.0% | 1,477,946 | -40.4% | 0.01% | 0.0% |
Q4 2016 | $5,063,000 | -24.5% | 2,481,740 | -0.9% | 0.01% | -33.3% |
Q3 2016 | $6,709,000 | +10.7% | 2,503,340 | +27.3% | 0.01% | 0.0% |
Q2 2016 | $6,059,000 | +1074.2% | 1,967,140 | +5071.2% | 0.01% | +1100.0% |
Q4 2015 | $516,000 | -86.3% | 38,040 | -90.3% | 0.00% | -88.9% |
Q3 2015 | $3,777,000 | +280.4% | 393,440 | +141.6% | 0.01% | +350.0% |
Q4 2014 | $993,000 | -74.7% | 162,840 | -56.0% | 0.00% | -81.8% |
Q3 2014 | $3,923,000 | -20.3% | 370,446 | -10.8% | 0.01% | 0.0% |
Q2 2014 | $4,923,000 | – | 415,440 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |